宫颈癌治疗启动与生存:居住地距癌症诊疗机构远近的作用
该回顾性队列研究纳入2001-2016年南卡罗来纳州2518例浸润性宫颈癌患者,分析驾车时间与治疗启动及病因特异性生存的关系。结果显示,到实际治疗机构的驾车时间超过30分钟与治疗启动延迟相关,但到最近癌症诊疗机构的驾车时间与生存或治疗启动无显著关联,两种驾车时间均与病因特异性生存无关。
要点
- 到实际治疗机构驾车超过30分钟与宫颈癌治疗启动延迟相关。
- 到最近癌症诊疗机构的驾车时间与生存或治疗启动无显著关联。
- 两种驾车时间均与病因特异性生存无关。
核心结论
- 宫颈癌患者到所选治疗机构的驾车时间,而非到最近癌症诊疗机构的驾车时间,与治疗启动时间延长相关。
- 两种驾车时间均与病因特异性生存无关。
研究设计与样本
- 回顾性队列分析,使用南卡罗来纳州中央癌症登记处数据并与生命记录链接,纳入2001-2016年诊断为浸润性宫颈癌的患者2518例。
- 采用Kaplan-Meier生存曲线和Cox比例风险模型分析驾车时间与病因特异性生存及治疗启动时间的关联。
主要发现
- 2518例 eligible 患者中,中位病因特异性生存为49个月(四分位距17-116),中位治疗启动时间为21天(四分位距0-40)。
- 与居住地距最近癌症诊疗机构15分钟以内的患者相比,距离超过30分钟的患者较少在教学医院、Joint Commission认证机构和/或Commission on Cancer认证机构接受初始治疗。
- 控制患者、临床和提供者特征后,到最近癌症诊疗机构的驾车时间与生存/治疗启动时间无显著关联。
- 到实际治疗机构驾车超过30分钟的患者治疗启动延迟(风险比0.81;95%CI 0.73-0.90),包括手术(0.82;95%CI 0.72-0.92)和放疗(0.82;95%CI 0.72-0.94)。
- 到首次治疗机构驾车超过30分钟与病因特异性生存较差无关。
临床怎么用
- 临床转诊宫颈癌患者时,应关注患者到实际治疗机构的驾车时间,超过30分钟可能提示治疗启动延迟风险。
- 仅评估到最近癌症诊疗机构的距离可能不足以识别治疗启动延迟风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the role of driving time to cancer care facilities on days to cancer treatment initiation and cause-specific survival for cervical cancer patients. METHODS: A retrospective cohort analysis of patients diagnosed with invasive cervical cancer during 2001-2016, using South Carolina Central Cancer Registry data linked to vital records. Kaplan-Meier survival curves and Cox proportional hazards models were used to examine the association of driving times to both a patient's nearest and actual cancer treatment initiation facility with cause-specific survival and time to treatment initiation. RESULTS: Of 2518 eligible patients, median cause-specific survival was 49 months (interquartile, 17-116) and time to cancer treatment initiation was 21 days (interquartile, 0-40). Compared to patients living within 15 min of the nearest cancer provider, those living more than 30 min away were less likely to receive initial treatment at teaching hospitals, Joint Commission accredited facilities, and/or Commission on Cancer accredited facilities. After controlling for patient, clinical, and provider characteristics, no significant associations existed between driving times to the nearest cancer provider and survival/time to treatment. When examining driving times to treatment initiation (rather than simply nearest) provider, patients who traveled farther than 30 min to their actual providers had delayed initiation of cancer treatment (hazard ratio, 0.81; 95% confidence interval, 0.73-0.90), including surgery (0.82; 95% CI, 0.72-0.92) and radiotherapy (0.82, 95% CI, 0.72-0.94). Traveling farther than 30 min to the first treating provider was not associated with worse cause-specific survival. CONCLUSIONS: For cervical cancer patients, driving time to chosen treatment providers, but not to the nearest cancer care provider, was associated with prolonged time to treatment initiation. Neither was associated with survival.
引用
- Hung P, Zahnd WE, Brandt HM, et al. Cervical cancer treatment initiation and survival: The role of residential proximity to cancer care. Gynecol Oncol. 2020. PMID: 33081985. doi:10.1016/j.ygyno.2020.10.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。